Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHutchmed Share News (HCM)

Share Price Information for Hutchmed (HCM)

Share Price is delayed by 15 minutes
Get Live Data
167.00    -2.50 (-1.47%)
Bid:
164.00
Ask:
172.00
Spread: 8.00 (4.878%)
Market Cap: £1.44b
HCM Live PriceLast checked at - London Stock Exchange

Intraday Hutchmed Share Chart

Hutchmed News

Hutchison Gains Fruquintinib Capsules Approval As Cancer Drug In China
5 Sep 2018

Hutchison Gains Fruquintinib Capsules Approval As Cancer Drug In China

LONDON (Alliance News) - Hutchison China Meditech Ltd said Wednesday it gained Chinese approval for its Fruquintinib capsules to be used as treatment ...

Hutchinson China Meditech Swings To Net Loss, Ups Annual Loss Estimate
27 Jul 2018

Hutchinson China Meditech Swings To Net Loss, Ups Annual Loss Estimate

LONDON (Alliance News) - Hutchison China Meditech Ltd on Friday raised its annual loss estimate by USD20 million after swinging to an interim net loss...

UK Earnings, Trading Statements Calendar - Next 7 Days
20 Jul 2018

UK Earnings, Trading Statements Calendar - Next 7 Days

Monday 23 July Ryanair HoldingsQ1 ResultsAscentialHalf Year Retail GroupHalf 24

Hutchison China Cancer Trial Shows Clinically Meaningful Benefits
4 Jun 2018

Hutchison China Cancer Trial Shows Clinically Meaningful Benefits

LONDON (Alliance News) - Biopharmaceutical company Hutchison China MediTech Ltd said Monday patients in its FRESCO Phase III study "demonstrated a sta...

UK Shareholder Meetings Calendar - Next 7 Days
20 Apr 2018

UK Shareholder Meetings Calendar - Next 7 Days

Monday 23 AprilForeign & Colonial Investment Trust BioquellMicrogenHgCapital

Hutchison China Meditech 2017 Loss Widens Amid Rising Research Costs
12 Mar 2018

Hutchison China Meditech 2017 Loss Widens Amid Rising Research Costs

LONDON (Alliance News) - China-focused drug developer and distributor Hutchison China Meditech PLC said Monday annual losses widened due to increased ...

Hutchison China Meditech Begins New Study For Epitinib Treatment
6 Mar 2018

Hutchison China Meditech Begins New Study For Epitinib Treatment

LONDON (Alliance News) - Pharmaceutical firm Hutchison China Meditech Ltd has started a phase Ib/II proof-of-concept study for its proposed brain canc...